Overview

A Study of Duloxetine in Patients With Osteoarthritis Knee Pain

Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to determine if duloxetine 60 mg once daily (QD) reduces pain severity in patients with osteoarthritis (OA) knee pain compared with placebo.
Phase:
Phase 3
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Duloxetine Hydrochloride